Every material Form 8-K JBT Marel filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
JBT Marel reported third-quarter 2026 results with revenue down 1% to $994 million, while net income rose 6% to $70 million and diluted EPS reached $1.34. The Board also raised the total share repurchase authorization to $700 million, and the company revised its full-year 2026 revenue outlook to reflect lower near-term volume expectations.
Q3 revenue $994 million, down 1% from $1,001 million; net income $70 million, up 6%.
Diluted EPS $1.34 vs. $1.26 a year earlier; adjusted EPS $2.19 vs. $1.94.
Board authorized a $500 million increase on October 30, 2026, bringing the total repurchase authorization to $700 million; about 800,000 shares repurchased for $94 million in Q3.
JBT Marel reported second quarter 2026 results with revenue up 5% to $981 million and diluted EPS of $0.54 versus $0.07 a year earlier. Results included a $33 million non-cash impairment charge, and the Prepared Food and Beverage Solutions segment came in below company expectations, while full-year revenue and adjusted EBITDA margin guidance was reiterated.
Q2 2026 revenue $981 million, up 5%; net income $28 million versus $3 million a year earlier
Diluted EPS $0.54 versus $0.07; adjusted EPS $1.95 versus $1.49
Prepared Food and Beverage Solutions revenue was flat at $514 million and adjusted EBITDA margin fell 70 basis points
FY 2026 adjusted EPS guidance refined to $7.85 - $8.35; GAAP diluted EPS guidance updated to $4.20 - $4.70
JBT Marel reported first quarter 2026 results on May 4, 2026, with revenue up 10% to $936 million and net income of $45 million, compared with a net loss of $173 million a year earlier. The company reiterated its full-year 2026 guidance, including revenue of $3,990 million to $4,065 million and adjusted EPS of $8.00 to $8.50.
Diluted EPS was $0.86 versus a loss of $3.35 a year earlier; adjusted EPS was $1.58 versus $0.97.
Orders totaled $1.07 billion and quarter-ending backlog was $1.49 billion.
Operating cash flow was $119 million and free cash flow was $100 million; net debt to trailing twelve months adjusted EBITDA was 2.6x.
Protein Solutions segment adjusted EBITDA margin was 21.7%, while Prepared Food and Beverage Solutions margin fell to 14.7%, down 170 basis points.
JBT Marel reported fourth quarter and full year 2025 results, with full year revenue of $3.8 billion and a loss from continuing operations of $50 million, compared with income of $84.6 million in 2024. The company also issued 2026 guidance calling for revenue of $3,990 million to $4,065 million and adjusted EPS of $8.00 to $8.50, which matters to shareholders because the 2025 GAAP loss was driven by a $147 million pension settlement charge and $115 million in M&A costs, while adjusted EPS rose to $6.41 from $6.15.
Full year 2025 revenue was $3.8 billion, up from $1.7 billion in 2024, and fourth quarter revenue was $1,008.0 million versus $467.6 million a year earlier.
Full year 2025 diluted loss per share from continuing operations was $0.96, compared with diluted earnings of $2.63 in 2024; adjusted EPS was $6.41 versus $6.15.
Full year 2026 guidance: revenue of $3,990 million to $4,065 million, GAAP EPS of $4.70 to $5.15, and adjusted EBITDA of $675 million to $710 million.
Full year 2025 free cash flow was $250 million, and net debt to trailing twelve months adjusted EBITDA was 2.9x; an Investor Day is scheduled for March 26, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every JBT Marel filing is on SEC EDGAR ↗. 8-K briefs of other companies →